Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Valacyclovir Oral Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 500mg tablet
  • 1.3.3 1000mg tablet
  • 1.3.4 300mg tablet
  • 1.3.5 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Valacyclovir Oral Market Share by Application (2019-2025)
  • 1.4.2 Hospital
  • 1.4.3 Drug store
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Valacyclovir Oral Market Size
  • 2.1.1 Global Valacyclovir Oral Revenue 2014-2025
  • 2.1.2 Global Valacyclovir Oral Sales 2014-2025
• 2.2 Valacyclovir Oral Growth Rate by Regions
  • 2.2.1 Global Valacyclovir Oral Sales by Regions 2014-2019
  • 2.2.2 Global Valacyclovir Oral Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Valacyclovir Oral Sales by Manufacturers
  • 3.1.1 Valacyclovir Oral Sales by Manufacturers 2014-2019
  • 3.1.2 Valacyclovir Oral Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Valacyclovir Oral Revenue by Manufacturers (2014-2019)
  • 3.2.2 Valacyclovir Oral Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Valacyclovir Oral Market Concentration Ratio (CR5 and HHI)
• 3.3 Valacyclovir Oral Price by Manufacturers
• 3.4 Key Manufacturers Valacyclovir Oral Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Valacyclovir Oral Market
• 3.6 Key Manufacturers Valacyclovir Oral Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 500mg tablet Sales and Revenue (2014-2019)
  • 4.1.2 1000mg tablet Sales and Revenue (2014-2019)
  • 4.1.3 300mg tablet Sales and Revenue (2014-2019)
  • 4.1.4 Others Sales and Revenue (2014-2019)
• 4.2 Global Valacyclovir Oral Sales Market Share by Type
• 4.3 Global Valacyclovir Oral Revenue Market Share by Type
• 4.4 Valacyclovir Oral Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Valacyclovir Oral Sales by Application

6 United States

• 6.1 United States Valacyclovir Oral Breakdown Data by Company
• 6.2 United States Valacyclovir Oral Breakdown Data by Type
• 6.3 United States Valacyclovir Oral Breakdown Data by Application

7 European Union

• 7.1 European Union Valacyclovir Oral Breakdown Data by Company
• 7.2 European Union Valacyclovir Oral Breakdown Data by Type
• 7.3 European Union Valacyclovir Oral Breakdown Data by Application

8 China

• 8.1 China Valacyclovir Oral Breakdown Data by Company
• 8.2 China Valacyclovir Oral Breakdown Data by Type
• 8.3 China Valacyclovir Oral Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Valacyclovir Oral Breakdown Data by Company
• 9.2 Rest of World Valacyclovir Oral Breakdown Data by Type
• 9.3 Rest of World Valacyclovir Oral Breakdown Data by Application
• 9.4 Rest of World Valacyclovir Oral Breakdown Data by Countries
  • 9.4.1 Rest of World Valacyclovir Oral Sales by Countries
  • 9.4.2 Rest of World Valacyclovir Oral Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 GSK
  • 10.1.1 GSK Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Valacyclovir Oral
  • 10.1.4 Valacyclovir Oral Product Introduction
  • 10.1.5 GSK Recent Development
• 10.2 Sandoz
  • 10.2.1 Sandoz Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Valacyclovir Oral
  • 10.2.4 Valacyclovir Oral Product Introduction
  • 10.2.5 Sandoz Recent Development
• 10.3 Sun Pharmaceutical
  • 10.3.1 Sun Pharmaceutical Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Valacyclovir Oral
  • 10.3.4 Valacyclovir Oral Product Introduction
  • 10.3.5 Sun Pharmaceutical Recent Development
• 10.4 Cipla
  • 10.4.1 Cipla Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Valacyclovir Oral
  • 10.4.4 Valacyclovir Oral Product Introduction
  • 10.4.5 Cipla Recent Development
• 10.5 Mylan
  • 10.5.1 Mylan Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Valacyclovir Oral
  • 10.5.4 Valacyclovir Oral Product Introduction
  • 10.5.5 Mylan Recent Development
• 10.6 Teva
  • 10.6.1 Teva Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Valacyclovir Oral
  • 10.6.4 Valacyclovir Oral Product Introduction
  • 10.6.5 Teva Recent Development
• 10.7 Zydus Pharmaceuticals
  • 10.7.1 Zydus Pharmaceuticals Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Valacyclovir Oral
  • 10.7.4 Valacyclovir Oral Product Introduction
  • 10.7.5 Zydus Pharmaceuticals Recent Development
• 10.8 West-Ward Pharmaceuticals
  • 10.8.1 West-Ward Pharmaceuticals Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Valacyclovir Oral
  • 10.8.4 Valacyclovir Oral Product Introduction
  • 10.8.5 West-Ward Pharmaceuticals Recent Development
• 10.9 Time Cap Labs
  • 10.9.1 Time Cap Labs Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Valacyclovir Oral
  • 10.9.4 Valacyclovir Oral Product Introduction
  • 10.9.5 Time Cap Labs Recent Development
• 10.10 Wockhardt
  • 10.10.1 Wockhardt Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Valacyclovir Oral
  • 10.10.4 Valacyclovir Oral Product Introduction
  • 10.10.5 Wockhardt Recent Development
• 10.11 Apotex
• 10.12 Aurobindo Pharma
• 10.13 Jubilant Pharma
• 10.14 Lunan Pharmaceutical
• 10.15 Shandong Luoxin Pharmaceutical Group
• 10.16 Tasly

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Valacyclovir Oral Sales Channels
  • 11.2.2 Valacyclovir Oral Distributors
• 11.3 Valacyclovir Oral Customers

12 Market Forecast

• 12.1 Global Valacyclovir Oral Sales and Revenue Forecast 2019-2025
• 12.2 Global Valacyclovir Oral Sales Forecast by Type
• 12.3 Global Valacyclovir Oral Sales Forecast by Application
• 12.4 Valacyclovir Oral Forecast by Regions
  • 12.4.1 Global Valacyclovir Oral Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Valacyclovir Oral Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Valacyclovir is used to treat herpes virus infections, including herpes labialis (also known as cold sores), herpes zoster (also known as shingles), and herpes simplex (also known as genital herpes) in adults. It is also used to treat chickenpox and cold sores in children.
In 2019, the market size of Valacyclovir Oral is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Valacyclovir Oral.

This report studies the global market size of Valacyclovir Oral, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Valacyclovir Oral sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GSK
Sandoz
Sun Pharmaceutical
Cipla
Mylan
Teva
Zydus Pharmaceuticals
West-Ward Pharmaceuticals
Time Cap Labs
Wockhardt
Apotex
Aurobindo Pharma
Jubilant Pharma
Lunan Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Tasly

Market Segment by Product Type
500mg tablet
1000mg tablet
300mg tablet
Others

Market Segment by Application
Hospital
Drug store

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Valacyclovir Oral status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Valacyclovir Oral manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Valacyclovir Oral are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025